Several studies have revealed that CD44s is highly expressed in situ and metastatic ovarian cancers and that CD44 expression is correlated with malignant behaviors of ovarian cancer cells, such as adhesion, invasion, and metastasis [3], [4]. The gene discussed is CD44; the disease is ovarian carcinoma.